1	Fluticasone	_	NN	_	_	2	NMOD	_	_
2	propionate	_	NN	_	_	3	VMOD	_	_
3	competes	_	VBZ	_	_	0	ROOT	_	_
4	with	_	IN	_	_	3	VMOD	_	_
5	phospho-GATA-3	_	NN	_	_	4	PMOD	_	_
6	for	_	IN	_	_	3	VMOD	_	_
7	importin-alpha	_	NN	_	_	6	PMOD	_	_
8	.	_	.	_	_	3	P	_	_
		
1	(	_	(	_	_	2	P	_	_
2	A	_	LS	_	_	5	VMOD	_	_
3	)	_	)	_	_	2	P	_	_
4	schematic	_	JJ	_	_	5	NMOD	_	_
5	representation	_	NN	_	_	0	ROOT	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	the	_	DT	_	_	12	NMOD	_	_
8	in	_	FW	_	_	9	AMOD	_	_
9	vitro	_	FW	_	_	12	NMOD	_	_
10	binding	_	NN	_	_	12	NMOD	_	_
11	competition	_	NN	_	_	12	NMOD	_	_
12	assay	_	NN	_	_	6	PMOD	_	_
13	.	_	.	_	_	5	P	_	_
		
1	(	_	(	_	_	2	P	_	_
2	B	_	LS	_	_	14	VMOD	_	_
3	)	_	)	_	_	2	P	_	_
4	GR	_	NN	_	_	14	VMOD	_	_
5	isolated	_	VBN	_	_	4	APPO	_	_
6	from	_	IN	_	_	5	VMOD	_	_
7	FP	_	NN	_	_	13	NMOD	_	_
8	(	_	(	_	_	10	P	_	_
9	10-8	_	CD	_	_	10	NMOD	_	_
10	M	_	NN	_	_	7	PRN	_	_
11	)	_	)	_	_	10	P	_	_
12	stimulated	_	VBN	_	_	13	NMOD	_	_
13	cells	_	NNS	_	_	6	PMOD	_	_
14	enhances	_	VBZ	_	_	0	ROOT	_	_
15	GR-importin-alpha	_	NN	_	_	16	NMOD	_	_
16	binding	_	NN	_	_	14	VMOD	_	_
17	in	_	IN	_	_	14	VMOD	_	_
18	the	_	DT	_	_	19	NMOD	_	_
19	presence	_	NN	_	_	17	PMOD	_	_
20	(	_	(	_	_	21	P	_	_
21	*	_	NN	_	_	19	PRN	_	_
22	)	_	)	_	_	21	P	_	_
23	and	_	CC	_	_	19	COORD	_	_
24	absence	_	NN	_	_	23	CONJ	_	_
25	(	_	(	_	_	26	P	_	_
26	==blacksquare	_	NN	_	_	24	PRN	_	_
27	,	_	,	_	_	26	P	_	_
28	square	_	NN	_	_	26	COORD	_	_
29	,	_	,	_	_	28	P	_	_
30	filled==	_	NN	_	_	28	COORD	_	_
31	)	_	)	_	_	26	P	_	_
32	of	_	IN	_	_	19	NMOD	_	_
33	activated	_	VBN	_	_	34	NMOD	_	_
34	GATA-3	_	NN	_	_	32	PMOD	_	_
35	.	_	.	_	_	14	P	_	_
		
1	*	_	NN	_	_	3	NMOD	_	_
2	p	_	NN	_	_	3	NMOD	_	_
3	<	_	NN	_	_	5	VMOD	_	_
4	0.05	_	CD	_	_	3	NMOD	_	_
5	compared	_	VBN	_	_	0	ROOT	_	_
6	to	_	TO	_	_	5	VMOD	_	_
7	no	_	DT	_	_	9	NMOD	_	_
8	activated	_	VBN	_	_	9	NMOD	_	_
9	GR	_	NN	_	_	6	PMOD	_	_
10	.	_	.	_	_	5	P	_	_
		
1	(	_	(	_	_	2	P	_	_
2	C	_	LS	_	_	4	NMOD	_	_
3	)	_	)	_	_	2	P	_	_
4	GATA-3	_	NN	_	_	9	VMOD	_	_
5	isolated	_	VBN	_	_	4	APPO	_	_
6	from	_	IN	_	_	5	VMOD	_	_
7	anti-CD3/CD28-stimulated	_	JJ	_	_	8	NMOD	_	_
8	cells	_	NNS	_	_	6	PMOD	_	_
9	does	_	VBZ	_	_	0	ROOT	_	_
10	not	_	RB	_	_	9	VMOD	_	_
11	attenuate	_	VB	_	_	9	VC	_	_
12	GR-importin-alpha	_	NN	_	_	13	NMOD	_	_
13	association	_	NN	_	_	11	VMOD	_	_
14	.	_	.	_	_	9	P	_	_
		
1	*p	_	NN	_	_	2	NMOD	_	_
2	<	_	NN	_	_	4	VMOD	_	_
3	0.05	_	CD	_	_	2	NMOD	_	_
4	compared	_	VBN	_	_	0	ROOT	_	_
5	to	_	TO	_	_	4	VMOD	_	_
6	control	_	NN	_	_	5	PMOD	_	_
7	.	_	.	_	_	4	P	_	_
		
1	(	_	(	_	_	2	P	_	_
2	D	_	LS	_	_	5	NMOD	_	_
3	)	_	)	_	_	2	P	_	_
4	Activated	_	JJ	_	_	5	NMOD	_	_
5	GR	_	NN	_	_	6	VMOD	_	_
6	blocks	_	VBZ	_	_	0	ROOT	_	_
7	the	_	DT	_	_	8	NMOD	_	_
8	ability	_	NN	_	_	6	VMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	purified	_	VBN	_	_	11	NMOD	_	_
11	phospho-GATA-3	_	NN	_	_	9	PMOD	_	_
12	isolated	_	VBN	_	_	11	APPO	_	_
13	from	_	IN	_	_	12	VMOD	_	_
14	anti-CD3/CD28-stimulated	_	JJ	_	_	15	NMOD	_	_
15	cells	_	NNS	_	_	13	PMOD	_	_
16	interacting	_	VBG	_	_	15	APPO	_	_
17	with	_	IN	_	_	16	VMOD	_	_
18	immobilised	_	JJ	_	_	19	NMOD	_	_
19	importin-alpha	_	NN	_	_	17	PMOD	_	_
20	in	_	IN	_	_	16	VMOD	_	_
21	an	_	DT	_	_	25	NMOD	_	_
22	in	_	FW	_	_	23	AMOD	_	_
23	vitro	_	FW	_	_	25	NMOD	_	_
24	binding	_	NN	_	_	25	NMOD	_	_
25	assay	_	NN	_	_	20	PMOD	_	_
26	.	_	.	_	_	6	P	_	_
		
1	*p	_	NN	_	_	2	NMOD	_	_
2	<	_	NN	_	_	4	VMOD	_	_
3	0.05	_	CD	_	_	2	NMOD	_	_
4	compared	_	VBN	_	_	0	ROOT	_	_
5	to	_	TO	_	_	4	VMOD	_	_
6	GATA-3	_	NN	_	_	5	PMOD	_	_
7	isolated	_	VBN	_	_	6	APPO	_	_
8	from	_	IN	_	_	7	VMOD	_	_
9	unstimulated	_	JJ	_	_	10	NMOD	_	_
10	cells	_	NNS	_	_	8	PMOD	_	_
11	.	_	.	_	_	4	P	_	_
		
1	#	_	NN	_	_	3	NMOD	_	_
2	p	_	NN	_	_	3	NMOD	_	_
3	<	_	NN	_	_	5	VMOD	_	_
4	0.05	_	CD	_	_	3	NMOD	_	_
5	compared	_	VBN	_	_	0	ROOT	_	_
6	to	_	TO	_	_	5	VMOD	_	_
7	stimulated	_	VBN	_	_	9	NMOD	_	_
8	GATA-3-importin	_	NN	_	_	9	NMOD	_	_
9	binding	_	NN	_	_	6	PMOD	_	_
10	.	_	.	_	_	5	P	_	_
		
1	(	_	(	_	_	2	P	_	_
2	E	_	NN	_	_	5	PRN	_	_
3	)	_	)	_	_	2	P	_	_
4	The	_	DT	_	_	5	NMOD	_	_
5	effect	_	NN	_	_	22	VMOD	_	_
6	of	_	IN	_	_	5	NMOD	_	_
7	activated	_	VBN	_	_	16	NMOD	_	_
8	(	_	(	_	_	9	P	_	_
9	*	_	NN	_	_	7	PRN	_	_
10	)	_	)	_	_	9	P	_	_
11	versus	_	CC	_	_	7	COORD	_	_
12	unstimulated	_	JJ	_	_	11	CONJ	_	_
13	(	_	(	_	_	14	P	_	_
14	o	_	NN	_	_	7	PRN	_	_
15	)	_	)	_	_	14	P	_	_
16	GR	_	NN	_	_	6	PMOD	_	_
17	on	_	IN	_	_	5	NMOD	_	_
18	attenuation	_	NN	_	_	17	PMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	GATA-3-importin-alpha	_	NN	_	_	21	NMOD	_	_
21	association	_	NN	_	_	19	PMOD	_	_
22	was	_	VBD	_	_	0	ROOT	_	_
23	concentration-dependent	_	JJ	_	_	22	VMOD	_	_
24	.	_	.	_	_	22	P	_	_
		
1	*p	_	NNP	_	_	2	NAME	_	_
2	<	_	NNP	_	_	6	VMOD	_	_
3	0.05	_	CD	_	_	2	NMOD	_	_
4	,	_	,	_	_	2	P	_	_
5	**p	_	CD	_	_	2	NMOD	_	_
6	<	_	JJ	_	_	0	ROOT	_	_
7	0.01	_	CD	_	_	6	VMOD	_	_
8	between	_	IN	_	_	6	VMOD	_	_
9	groups	_	NNS	_	_	8	PMOD	_	_
10	.	_	.	_	_	6	P	_	_
		
1	All	_	DT	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	are	_	VBP	_	_	0	ROOT	_	_
4	expressed	_	VBN	_	_	3	VC	_	_
5	as	_	IN	_	_	4	VMOD	_	_
6	mean+/-SEM	_	NN	_	_	5	PMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	three	_	CD	_	_	10	NMOD	_	_
9	independent	_	JJ	_	_	10	NMOD	_	_
10	experiments	_	NNS	_	_	7	PMOD	_	_
11	and	_	CC	_	_	4	COORD	_	_
12	analysed	_	VBN	_	_	11	CONJ	_	_
13	by	_	IN	_	_	12	VMOD	_	_
14	ANOVA	_	NN	_	_	13	PMOD	_	_
15	followed	_	VBN	_	_	14	APPO	_	_
16	by	_	IN	_	_	15	VMOD	_	_
17	Newman-Keuls	_	NN	_	_	18	NMOD	_	_
18	post-test	_	NN	_	_	16	PMOD	_	_
19	.	_	.	_	_	3	P	_	_
		
